Mesalamine Tablet, Delayed Release
Product Images NDC 51407-900

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 51407-900). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Golden State Medical Supply, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51407-900-12ol (Mesalamine DR 1.2g)

Each delayed-release tablet contains 1.2 g of Mesalamine, USP. These tablets are intended to be dispensed in a tight, light-resistant container as per USP guidelines. It is important to keep this medication out of reach of children and store it at a temperature between 20°C - 25°C (68°F - 77°F) as recommended by the USP. This medication is to be taken once daily. This product is marketed by GSMS, Incorporated in Camarillo, CA, USA. For more information, refer to the label and consult with a pharmacist or healthcare provider.*

FDA Label Image

Image (A80b40d7 4498 4dfa B5ff B29ee69471a9 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.